TABLE 1

Animal Tumor Models and Treatments

TumorTreatment (mg/kg) on day 0–day 2
HCC827Erlotinib (50)
Erlotinib (150)
H1975Erlotinib (50)
Erlotinib (150)
CL-387,785 (50)
WZ4002 (25)
WZ4002 (50)
H1650Erlotinib (50)
Erlotinib (150)
ABT-263 (6.25)
Erlotinib (50) + ABT-263 (6.25)
  • Treatment was started 3 h after baseline 18F-FLT scan on day 0 and was stopped 3 h before posttreatment 18F-FLT scan on day 2.